Rocket Pharmaceuticals RCKT Q1 2025 earnings
Reported May 8, 2025 · Before market open
EPS-$0.56Beat by $0.03
Revenue estimate$800.0K
EPS estimate-$0.59
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$222.2K
EPS estimate$1.04
Versus estimates
Diluted EPS
Ask the moment Rocket Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Rocket Pharmaceuticals report Q1 2025 earnings?
- Rocket Pharmaceuticals (RCKT) reported Q1 2025 earnings on May 8, 2025 before market open.
- What were Rocket Pharmaceuticals's Q1 2025 revenue and EPS?
- Rocket Pharmaceuticals reported eps of $-0.56 for Q1 2025.
- Did Rocket Pharmaceuticals beat estimates in Q1 2025?
- EPS beat the consensus estimate of $-0.59 by $0.03.
- How did Rocket Pharmaceuticals's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 15.2% from $-0.66.
- Where can I find Rocket Pharmaceuticals's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-066898) directly on SEC EDGAR. The filing index links above go to sec.gov.